APA (7th ed.) Citation

Y, S., T, S., R, A., K, O., M, Y., S, O., & K, U. (2023). ASO Author Reflections: Prognostic Role of Preoperative Duke Pancreatic Monoclonal Antigen Type 2 Values in Patients with Pancreatic Cancer: Focusing on the Usefulness in Patients with Normal CA19-9. Annals of surgical oncology, 30(9), 5801. https://doi.org/10.1245/s10434-023-13629-7

Chicago Style (17th ed.) Citation

Y, Shimizu, Sugiura T, Ashida R, Ohgi K, Yamada M, Otsuka S, and Uesaka K. "ASO Author Reflections: Prognostic Role of Preoperative Duke Pancreatic Monoclonal Antigen Type 2 Values in Patients with Pancreatic Cancer: Focusing on the Usefulness in Patients with Normal CA19-9." Annals of Surgical Oncology 30, no. 9 (2023): 5801. https://doi.org/10.1245/s10434-023-13629-7.

MLA (9th ed.) Citation

Y, Shimizu, et al. "ASO Author Reflections: Prognostic Role of Preoperative Duke Pancreatic Monoclonal Antigen Type 2 Values in Patients with Pancreatic Cancer: Focusing on the Usefulness in Patients with Normal CA19-9." Annals of Surgical Oncology, vol. 30, no. 9, 2023, p. 5801, https://doi.org/10.1245/s10434-023-13629-7.